Orthofix Medical (NASDAQ:OFIX – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare Orthofix Medical to related businesses based on the strength of its analyst recommendations, valuation, profitability, dividends, institutional ownership, earnings and risk.
Analyst Recommendations
This is a summary of recent ratings and price targets for Orthofix Medical and its rivals, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Orthofix Medical | 1 | 1 | 3 | 0 | 2.40 |
| Orthofix Medical Competitors | 4314 | 10603 | 18404 | 838 | 2.46 |
Orthofix Medical currently has a consensus price target of $13.50, suggesting a potential upside of 102.40%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 23.29%. Given Orthofix Medical’s higher probable upside, equities analysts plainly believe Orthofix Medical is more favorable than its rivals.
Insider & Institutional Ownership
89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Risk and Volatility
Orthofix Medical has a beta of 0.66, indicating that its share price is 34% less volatile than the S&P 500. Comparatively, Orthofix Medical’s rivals have a beta of 2.58, indicating that their average share price is 158% more volatile than the S&P 500.
Earnings & Valuation
This table compares Orthofix Medical and its rivals gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Orthofix Medical | $822.31 million | -$92.19 million | -5.96 |
| Orthofix Medical Competitors | $1.87 billion | $136.27 million | 5.73 |
Orthofix Medical’s rivals have higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Profitability
This table compares Orthofix Medical and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Orthofix Medical | -5.39% | -10.32% | -5.19% |
| Orthofix Medical Competitors | -269.88% | -187.36% | -21.77% |
Summary
Orthofix Medical rivals beat Orthofix Medical on 7 of the 13 factors compared.
Orthofix Medical Company Profile
Orthofix Medical Inc. develops and markets medical technologies for spine and orthopedic care. Its products include spinal implants and biologics, bone growth stimulation systems, and solutions used in fracture treatment and limb reconstruction. The company serves hospitals, surgeons, and other health care providers through its Orthofix and SeaSpine businesses. Its offerings span surgical products as well as noninvasive and specialized orthopedic treatments. Orthofix and SeaSpine completed a merger in 2023, combining their spine and orthopedic product portfolios.
Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.
